Trastuzumab
Cardiac dysfunction in the trastuzumab clinical trials experience.
2–46 Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oes...
[Trastuzumab in combination with chemotherapy versus chemotherapy alone for first-line treatment of HER2-positive advanced gastric o...
Adjuvant Herceptin- Original NSABP & NCCTG data (Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-p...
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth ...
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells.
